Related references
Note: Only part of the references are listed.Estimating the sample mean and standard deviation from commonly reported quantiles in meta-analysis
Sean McGrath et al.
STATISTICAL METHODS IN MEDICAL RESEARCH (2020)
Evaluation of different antiandrogenic progestins on clinical and biochemical variables in polycystic ovary syndrome
Giuseppe Morgante et al.
EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE (2020)
Effect of the combined oral contraceptive pill and/or metformin in the management of polycystic ovary syndrome: A systematic review with meta-analyses
Helena Teede et al.
CLINICAL ENDOCRINOLOGY (2019)
Effect of orlistat or metformin in overweight and obese polycystic ovary syndrome patients with insulin resistance
Jinghua Song et al.
GYNECOLOGICAL ENDOCRINOLOGY (2018)
Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome
Helena J. Teede et al.
HUMAN REPRODUCTION (2018)
The effects of different therapeutic modalities on cardiovascular risk factors in women with polycystic ovary syndrome: A randomized controlled study
Serkan Bodur et al.
TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY (2018)
Combined oral contraceptives plus spironolactone compared with metformin in women with polycystic ovary syndrome: a one-year randomized clinical trial
Macarena Alpanes et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2017)
Management of polycystic ovarian syndrome with Diane-35 or Diane-35 plus metformin
Wei Feng et al.
GYNECOLOGICAL ENDOCRINOLOGY (2016)
Metformin improves endothelial function and carotid intima media thickness in patients with PCOS
Mehmet Gungor Kaya et al.
GYNECOLOGICAL ENDOCRINOLOGY (2015)
Body Composition Is Improved During 12 Months' Treatment With Metformin Alone or Combined With Oral Contraceptives Compared With Treatment With Oral Contraceptives in Polycystic Ovary Syndrome
Dorte Glintborg et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Effects of Drospirenone-Ethinylestradiol and/or Metformin on CD4+CD28null T Lymphocytes Frequency in Women With Hyperinsulinemia Having Polycystic Ovary Syndrome: A Randomized Clinical Trial
Francesca Moro et al.
REPRODUCTIVE SCIENCES (2013)
Lifestyle intervention and anti-obesity therapies in the polycystic ovary syndrome: impact on metabolism and fertility
Dimitrios Panidis et al.
ENDOCRINE (2013)
Safety of antiobesity drugs
Bernard Man Yung Cheung et al.
THERAPEUTIC ADVANCES IN DRUG SAFETY (2013)
Long-Term Safety, Tolerability, and Weight Loss Associated With Metformin in the Diabetes Prevention Program Outcomes Study
George A. Bray et al.
DIABETES CARE (2012)
A clinical study on the short-term effect of berberine in comparison to metformin on the metabolic characteristics of women with polycystic ovary syndrome
Wei Wei et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2012)
Ethinylestradiol30μg-drospirenone and metformin: could this combination improve endothelial dysfunction in polycystic ovary syndrome?
Ioana Rada Ilie et al.
BMC ENDOCRINE DISORDERS (2012)
Metabolic effects of contraceptive steroids
Regine Sitruk-Ware et al.
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS (2011)
Deep vein thrombosis in a woman taking oral combined contraceptive pills
Kiran G. Piparva et al.
JOURNAL OF PHARMACOLOGY & PHARMACOTHERAPEUTICS (2011)
Comparison of four different treatment regimens on coagulation parameters, hormonal and metabolic changes in women with polycystic ovary syndrome
Levent Kebapcilar et al.
ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2010)
Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan
H. Teede et al.
BMC MEDICINE (2010)
Effect of oral contraceptives on markers of hyperandrogenism and SHBG in women with polycystic ovary syndrome
Vincenzo De Leo et al.
CONTRACEPTION (2010)
The Effect of Ethinylestradiol (EE)/Cyproterone Acetate (CA) and EE/CA Plus Metformin Treatment on Adhesion Molecules in Cases with Polycystic Ovary Syndrome (PCOS)
Oktay Bilgir et al.
INTERNAL MEDICINE (2009)
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
David Moher et al.
BMJ-BRITISH MEDICAL JOURNAL (2009)
A comparison between rimonabant and metformin in reducing biochemical hyperandrogenaemia and insulin resistance in patients with polycystic ovary syndrome (PCOS): a randomized open-label parallel study
Thozhukat Sathyapalan et al.
CLINICAL ENDOCRINOLOGY (2008)
Effects of metformin and ethinyl estradiol-cyproterone acetate on clinical, endocrine and metabolic factors in women with polycystic ovary syndrome
Jie Wu et al.
GYNECOLOGICAL ENDOCRINOLOGY (2008)
GRADE:: an emerging consensus on rating quality of evidence and strength of recommendations
Gordon H. Guyatt et al.
BRITISH MEDICAL JOURNAL (2008)
Metformin administration is more effective when non-obese patients with polycystic ovary syndrome show both hyperandrogenism and hyperinsulinemia
Alessandro D. Genazzani et al.
GYNECOLOGICAL ENDOCRINOLOGY (2007)
Prevalence and characteristics of the polycystic ovary syndrome in overweight and obese women
Francisco Alvarez-Blasco et al.
ARCHIVES OF INTERNAL MEDICINE (2006)
Low-dose flutamide-metformin therapy for hyperinsulinemic hyperandrogenism in non-obese adolescents and women
L Ibáñez et al.
HUMAN REPRODUCTION UPDATE (2006)
Improvement in endothelial structure and function after metformin treatment in young normal-weight women with polycystic ovary syndrome: Results of a 6-month study
F Orio et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Overweight women with polycystic ovary syndrome have evidence of subclinical cardiovascular disease
C Meyer et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Orlistat is as beneficial as metformin in the treatment of polycystic ovarian syndrome
V Jayagopal et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
The effect of combination therapy with metformin and combined oral contraceptives (COC) versus COC alone on insulin sensitivity, hyperandrogenaemia, SHBG and lipids in PCOS patients
D Cibula et al.
HUMAN REPRODUCTION (2005)
Metformin versus ethinyl estradiol-cyproterone acetate in the treatment of nonobese women with polycystic ovary syndrome: A randomized study
L Morin-Papunen et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Sibutramine has a positive effect on clinical and metabolic parameters in obese patients with polycystic ovary syndrome
T Sabuncu et al.
FERTILITY AND STERILITY (2003)
Clinical, endocrine and metabolic effects of metformin added to ethinyl estradiol-cyproterone acetate in non-obese women with polycystic ovarian syndrome: a randomized controlled study
K Elter et al.
HUMAN REPRODUCTION (2002)
Systematic reviews in health care - Investigating and dealing with publication and other biases in meta-analysis
JAC Sterne et al.
BMJ-BRITISH MEDICAL JOURNAL (2001)
Share Paper
